Qrons Inc Stock Performance
| QRON Stock | USD 0.18 0.01 5.26% |
The company holds a Beta of 0.18, which implies not very significant fluctuations relative to the market. As returns on the market increase, Qrons' returns are expected to increase less than the market. However, during the bear market, the loss of holding Qrons is expected to be smaller as well. At this point, Qrons Inc has a negative expected return of -0.0518%. Please make sure to check Qrons' jensen alpha and rate of daily change , to decide if Qrons Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Qrons Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Qrons is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 57.6 K | |
| Free Cash Flow | -122.6 K |
Qrons |
Qrons Relative Risk vs. Return Landscape
If you would invest 19.00 in Qrons Inc on September 12, 2024 and sell it today you would lose (1.00) from holding Qrons Inc or give up 5.26% of portfolio value over 90 days. Qrons Inc is currently does not generate positive expected returns and assumes 2.4411% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of otc stocks are less volatile than Qrons, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Qrons Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qrons' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Qrons Inc, and traders can use it to determine the average amount a Qrons' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0212
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | QRON |
Estimated Market Risk
| 2.44 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Qrons is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qrons by adding Qrons to a well-diversified portfolio.
Qrons Fundamentals Growth
Qrons OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Qrons, and Qrons fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Qrons OTC Stock performance.
| Return On Asset | -14.92 | |||
| Current Valuation | 7.05 M | |||
| Shares Outstanding | 13.29 M | |||
| Price To Book | 144.78 X | |||
| EBITDA | (859.09 K) | |||
| Cash And Equivalents | 8.35 K | |||
| Total Debt | 370 K | |||
| Debt To Equity | 23.30 % | |||
| Book Value Per Share | (0.09) X | |||
| Cash Flow From Operations | (122.57 K) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 35.06 K | |||
About Qrons Performance
By examining Qrons' fundamental ratios, stakeholders can obtain critical insights into Qrons' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Qrons is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York. Qrons operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about Qrons Inc performance evaluation
Checking the ongoing alerts about Qrons for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Qrons Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Qrons Inc generated a negative expected return over the last 90 days | |
| Qrons Inc has some characteristics of a very speculative penny stock | |
| Qrons Inc has a very high chance of going through financial distress in the upcoming years | |
| Qrons Inc currently holds 370 K in liabilities with Debt to Equity (D/E) ratio of 23.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Qrons Inc has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Qrons until it has trouble settling it off, either with new capital or with free cash flow. So, Qrons' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qrons Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qrons to invest in growth at high rates of return. When we think about Qrons' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Qrons Inc currently holds about 8.35 K in cash with (122.57 K) of positive cash flow from operations. | |
| Roughly 76.0% of Qrons outstanding shares are owned by corporate insiders |
- Analyzing Qrons' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Qrons' stock is overvalued or undervalued compared to its peers.
- Examining Qrons' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Qrons' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Qrons' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Qrons' otc stock. These opinions can provide insight into Qrons' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Qrons OTC Stock
Qrons financial ratios help investors to determine whether Qrons OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Qrons with respect to the benefits of owning Qrons security.